Study guide

2.4 NPIAP Pressure Injury Staging (Stages 1-4, Unstageable, DTPI)

NAWCCB WCC Wound Care Certified Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

About the NAWCCB WCC Exam How to Use This Study Guide

2 Assessment: Skin & Tissue Foundations

1.1 Skin Anatomy, Physiology, and Barrier Function 1.2 Phases of Wound Healing & Cellular Events 1.3 Acute vs. Chronic Wounds & Etiology Classification 1.4 TIME and MEASURE Assessment Frameworks 1.5 Wound Bed Tissue Types & Periwound Assessment 1.6 Pain Assessment: Scales, Wound Pain Types, and Procedural Analgesia 1.7 Psychosocial History, Cognitive Status, and Functional Assessment 1.8 Skin Integrity Across the Lifespan: Neonatal, Pediatric, Adult, and Geriatric

3 Assessment: Diagnostic Tools & Risk Assessment

2.1 Vascular Assessment: ABI, TcPO2, and Arterial/Venous Doppler 2.2 Neuropathy & Monofilament Testing in Diabetic Patients 2.3 Pressure Injury Risk Assessment: Braden Scale Subscales & Scoring 2.4 NPIAP Pressure Injury Staging (Stages 1-4, Unstageable, DTPI) 2.5 Exudate Characterization, Biofilm (NERDS/STONEES), & Wound Culture 2.6 Laboratory Interpretation in Wound Care: Albumin, Prealbumin, ESR, A1C, CBC, and CMP 2.7 Risk Assessment Instruments Beyond Braden: Norton, Braden Q, Braden QD, Wagner, and University of Texas

4 Treatment: Dressing Selection & Debridement Modalities

3.1 Principles of Dressing Selection by Exudate & Moisture Balance 3.2 High-Absorbency Dressings: Alginates, Hydrofibers, and Foams 3.3 Barrier & Hydrating Dressings: Hydrocolloids, Transparent Films, and Hydrogels 3.4 Antimicrobial & Biofilm Dressings: Silver, Cadexomer Iodine, and Honey 3.5 Debridement Modalities: Sharp, Enzymatic, Autolytic, Mechanical, & Biosurgical

5 Treatment: Advanced Therapies & Specialized Management

4.1 Negative Pressure Wound Therapy (NPWT) Indications, Settings, & Precautions 4.2 Compression Therapy Protocols & ABI Safety Cutoffs 4.3 DFU Off-loading Hierarchy: TCC, RCW, and Therapeutic Footwear 4.4 Support Surfaces, Microclimate Control, & Repositioning Protocols 4.5 Advanced Biologics, Cellular/Tissue Products (CTPs), & HBOT

6 Reevaluation & Wound Healing Trajectory

5.1 Healing Trajectory Benchmarks & Percent Area Reduction (PAR) 5.2 Serial Wound Measurement, Depth Profiling, & Digital Photography 5.3 Treatment Plan Reassessment & Non-Healing Wound Escalation Triggers 5.4 Biofilm Progression & Systemic Infection Re-evaluation 5.5 Palliative Wound Management: Odor, Exudate, and Pain Control 5.6 Validated Healing Instruments: The PUSH Tool, BWAT, and Evaluating Adherence

7 Risk Reduction & Prevention Strategies

6.1 Pressure Injury Prevention: Bundles, Turning Schedules, & Heel Floating 6.2 Moisture-Associated Skin Damage (MASD) & Incontinence-Associated Dermatitis (IAD) 6.3 Infection Control, Contact Precautions, & Environmental Hygiene 6.4 Prevention of Skin Tears & Medical Adhesive-Related Skin Injuries (MARSI) 6.5 Diabetic & Venous Ulcer Recurrence Prevention Protocols 6.6 At-Risk Populations: Spinal Cord Injury, Stroke, Critical Care, and Cognitive Impairment

8 Patient & Caregiver Education

7.1 Patient & Caregiver Wound Care Teaching & Self-Management 7.2 Diabetic Foot Self-Inspection & Footwear Education 7.3 Nutritional Assessment & Dietary Interventions for Wound Healing 7.4 Off-loading Compliance & Patient Mobility Education 7.5 Recognizing Complications, Infection Signs, & When to Seek Care 7.6 Educating the Interprofessional Team & Developing Educational Media

9 Administration & Program Management

8.1 Wound Care Documentation Standards & Clinical Records 8.2 Admission Wound Screening & Present on Admission (POA) Documentation 8.3 Interdisciplinary Team Roles & Clinical Care Coordination 8.4 Quality Improvement Metrics & HAPI Tracking Programs 8.5 Wound Care Formulary Management & Resource Utilization

10 Legal, Ethical, & Scope of Practice

9.1 Informed Consent, Treatment Refusal, & Autonomy in Wound Care 9.2 HIPAA Compliance & Clinical Photography Privacy Standards 9.3 Scope of Practice Across WCC-Eligible Professions (RN, LPN, PT, OT, DPM, MD/DO, PA) 9.4 HAPI Malpractice Liability & Documentation Defense 9.5 Ethical Considerations in Non-Healing Wounds & End-of-Life Skin Care 9.6 Regulatory Compliance, Coding Standards, & Audit Protection

2.4 NPIAP Pressure Injury Staging (Stages 1-4, Unstageable, DTPI)

Key Takeaways Explain This Topic AI

Stage 1 and Stage 2 Pressure Injuries involve intact skin with non-blanchable erythema or partial-thickness loss exposing dermis without slough or eschar.

Stage 3 and Stage 4 Pressure Injuries involve full-thickness skin loss exposing adipose tissue (Stage 3) or deep structures such as muscle, tendon, and bone (Stage 4).

Unstageable Pressure Injuries are obscured by slough or eschar; stable, dry, intact eschar on heels or ischemic limbs must NOT be debrided.

Deep Tissue Pressure Injury (DTPI) presents as persistent non-blanchable deep red, maroon, or purple discoloration, or a blood-filled blister from deep muscle-bone interface pressure.

Pressure injuries are NEVER reverse staged during healing; a healing Stage 4 is documented as a 'healing Stage 4 pressure injury,' not reclassified as Stage 3 or 2.

Last updated: August 2026

NPIAP Pressure Injury Staging (Stages 1-4, Unstageable, DTPI)

Pressure injuries are localized damage to the skin and underlying soft tissue, usually over a bony prominence or related to a medical or other device. The National Pressure Injury Advisory Panel (NPIAP) system defines standard clinical staging criteria based on the anatomical depth of tissue destruction. Accurate staging guides dressing selection, surgical intervention, quality tracking, and legal documentation.

Detailed NPIAP Staging Definitions Anatomical Depth Breakdown of Pressure Injury Staging:

  • [ Epidermis ] --> Stage 1: Non-blanchable erythema (Skin Intact)
  • [ Dermis ] --> Stage 2: Partial-thickness skin loss (Exposed Dermis)
  • [ Subcutis ] --> Stage 3: Full-thickness skin loss (Exposed Adipose)
  • [ Muscle/Bone] --> Stage 4: Full-thickness tissue loss (Exposed Bone/Muscle)
  • * Obscured by Slough/Eschar --> Unstageable
  • * Maroon/Purple Intact Skin --> Deep Tissue Pressure Injury (DTPI)
  • Stage 1 Pressure Injury: Intact Skin with Non-Blanchable Erythema

Clinical Presentation: Intact skin with a localized area of non-blanchable erythema (redness that does not turn white when light finger pressure is applied).

Assessment in Dark Skin Tones: Non-blanchable erythema may present differently in darkly pigmented skin; it may appear as persistent deep red, purple, or blue discoloration without obvious blanching. Localized changes in skin temperature (warmth or coolness), tissue firmness (indurated or boggy feel), and pain precede visual color changes.

Exclusions: Does not include purple or maroon discoloration (which indicates DTPI).

Stage 2 Pressure Injury: Partial-Thickness Skin Loss with Exposed Dermis

Clinical Presentation: Partial-thickness loss of skin with exposed dermis. The wound bed is viable, pink or red, moist, and shallow.

Blister Presentation: May present as an intact or ruptured serum-filled blister .

Tissues Present/Absent: Adipose (fat) tissue, slough, eschar, and granulation tissue are absent .

Exclusions: Stage 2 must never be used to describe Moisture-Associated Skin Damage (MASD), Incontinence-Associated Dermatitis (IAD), intertriginous dermatitis, skin tears, or medical adhesive-related skin injuries (MARSI).

Stage 3 Pressure Injury: Full-Thickness Skin Loss

Clinical Presentation: Full-thickness loss of skin in which adipose (subcutaneous fat) tissue is visible in the ulcer. Granulation tissue and epibole (rolled wound edges) are frequently present.

Associated Features: Slough and/or eschar may be visible. Undermining and tunneling may occur.

Tissues Absent: Fascia, muscle, tendon, ligament, cartilage, and bone are NOT exposed or directly palpable.

Anatomical Depth Variation: Depth varies by anatomical location. Areas lacking subcutaneous fat (e.g., nose, ear, occiput, malleolus) yield shallow Stage 3 injuries, whereas adiposity-rich areas (e.g., gluteal region) can develop extremely deep Stage 3 ulcers.

Stage 4 Pressure Injury: Full-Thickness Skin and Tissue Loss

Clinical Presentation: Full-thickness skin and tissue loss with exposed or directly palpable fascia, muscle, tendon, ligament, cartilage, or bone within the ulcer.

Associated Features: Slough and/or eschar may be visible. Epibole, undermining, and tunneling frequently occur.

Clinical Risk: High risk for osteomyelitis, deep space infection, and systemic sepsis.

Unstageable Pressure Injury: Obscured Full-Thickness Skin and Tissue Loss

Clinical Presentation: Full-thickness skin and tissue loss in which the extent of tissue damage within the ulcer cannot be confirmed because it is obscured by slough or eschar .

Staging Rule: If slough or eschar is debrided, a Stage 3 or Stage 4 pressure injury will be revealed.

The Heel Eschar Exception: Stable (dry, adherent, intact without erythema or fluctuance) eschar on the heels or ischemic limbs serves as the body's natural biological cover and must NOT be removed or debrided .

Deep Tissue Pressure Injury (DTPI)

Clinical Presentation: Intact or non-intact skin with a localized area of persistent non-blanchable deep red, maroon, or purple discoloration , or epidermal separation revealing a dark wound bed or blood-filled blister.

Pathophysiology: Caused by intense and/or prolonged pressure and shear forces at the muscle-bone interface.

Evolution: The wound may evolve rapidly to reveal the extent of tissue injury (Stage 3 or 4) or may resolve without tissue loss if pressure is promptly relieved.

Special Classification Categories

Medical Device-Related Pressure Injury (MDRPI):

Results from the use of devices designed and applied for diagnostic or therapeutic purposes (e.g., endotracheal tubes, tracheostomy ties, cervical collars, CPAP masks, urinary catheters).

The pressure injury generally conforms to the pattern or shape of the device.

MDRPIs are staged using the standard NPIAP staging categories.

Mucosal Membrane Pressure Injury:

Found on mucous membranes with a history of a medical device in use at the location of the injury (e.g., endotracheal tube pressure on lips/tongue, Foley catheter pressure on urethral meatus).

Due to the unique histology of non-keratinized mucosal tissue (lacking a true dermis and epidermis), mucosal membrane pressure injuries cannot be assigned an NPIAP numerical stage .

Staging Integrity & Reverse Staging Prohibition

Mandatory Rule: Pressure injuries are NEVER reverse staged as they heal. A Stage 4 pressure injury that fills with granulation tissue is documented as a "healing Stage 4 pressure injury" (or Stage 4 in the proliferative phase), NEVER reclassified as a Stage 3 or Stage 2. Re-categorizing a healing Stage 4 as Stage 2 understates tissue destruction and violates clinical documentation standards.

  • Stage Category Skin Integrity Tissue Layers Exposed / Visible Slough / Eschar Present? Blister Feature
  • Stage 1 Intact None (Non-blanchable erythema) No No
  • Stage 2 Non-Intact Dermis only (Viable pink/red bed) No Intact or ruptured serum-filled blister
  • Stage 3 Non-Intact Subcutaneous Adipose tissue May be present No
  • Stage 4 Non-Intact Muscle, Tendon, Bone, Fascia May be present No
  • Unstageable Non-Intact Obscured by tissue coverage Yes (Obscuring bed) No
  • DTPI Intact or Split Dark wound bed / Blood-filled Variable Intact or ruptured blood-filled blister

Loading diagram... NPIAP Staging Differential Decision Tree